
Cleerly

Based in Denver, Colorado, Cleerly is revolutionizing the prevention of heart disease by combining advanced medical imaging and artificial intelligence. Its platform analyzes coronary CT angiograms (CCTA) to detect, quantify and characterize atherosclerotic plaques, identifying patients at risk more accurately than traditional methods.
Cleerly's technology draws on over 10 million images from 40,000 patients collected over 15 years, consolidating a robust scientific basis for its analyses.